Can the iPad Save Pharma Sales?
After years of falling pharma sales, the industry finally has a new tool. But can the iPad really transform these trends or is it a tech fad that will burst like the dot-com bubble? Boyan Zuzek, CIO at EKR Therapeutics, offers his views in Part One of this special Pharma Faceoff episode ...Click to watch

Does Pharma Have a Debt Crisis Strategy?
It’s unlikely that the U.S. will be pushed into default as a result of Congressional histrionics over the debt ceiling, but that doesn’t mean spending on Medicare and Medicaid will be left off the chopping block, putting pharma back on the hook. In Europe, the debt crisis has dire pricing implications ...Read more

An Exec's Perspective on Doing More with Less
Steven Blum, Director of Health Economics at Forest Laboratories and one of Pharm Exec's 2011 Emerging Pharma leaders, discusses how he builds team rapport in today's lean organization ...Read More

A 'Turning Point' in Drug Development
Some drugmakers have blamed what they see as a slow and overly cautious FDA for the industry’s weak pipelines. But Erik Greb takes closer look at the figures and sees the industry’s pipelines may not be so weak after all ...Read More

Pfizer Brings Clinical Trials Home
Remote trial management promises to reshape pre and post-market clinical studies …Read more

Making the Case for Training
Focusing on company training needs beyond sales and marketing can maximize the training department’s ROI …Read more

Gladiators of the Digital Age
How can reps remain essential as access continues to shrink and the industry turns to online sales tactics? The answer is simple: Fight …Read more